Posts Tagged ‘chronic kidney disease’

FDA yesterday approved Ozempic (semaglutide) to prevent kidney failure and death in persons with type 2 diabetes and chronic kidney disease. This fits with one of the five trends for this year: the steady expansion of health benefits for advanced medicines used in obesity and diabetes. But note that this approval covers the use of […]

Thankfully, 2024 is behind us now and we have a blank slate for a whole new year ahead of us. But what can we expect? Well, proverbial (probably Danish) wisdom tells us “prediction is difficult, especially if it’s about the future.” Nonetheless, here are our top five predictions about what we will see in 2025 […]

This moment has been a long time coming. Solid evidence that people live longer, healthier lives when they receive effective treatment for obesity is adding up. On Friday, we learned that semaglutide cuts kidney failure and death in diabetes. Then, over the weekend, Nature Medicine published a study showing that semaglutide may prevent kidney disease […]

We’ve been waiting for this. Back in October, headlines flashed the news that Novo Nordisk had stopped a big outcomes study of semaglutide and its effect on kidney failure and death. They stopped it because it had worked so well. Continuing to give a placebo to half the people in the study would have been […]

For some time now, scientists have noted that GLP-1 agonists have effects on more than just blood sugar and body weight. They seem to have an effect on systemic inflammation. For more than a decade, researchers have been exploring their anti-inflammatory effects. But a key question has remained: exactly how do GLP-1 agonists help with […]

The handwriting is on the wall. Insurers can’t avoid covering obesity drugs forever, said a recent analysis from Bloomberg and they were right. What prompted that conclusion is the cascade of health outcome studies that make it unmistakeable. Treating obesity and and related metabolic diseases with advanced medicines like semaglutide has a dramatic effect on […]